The availability of a functional tumor targeting T-cell repertoire determines the anti-tumor efficiency of combination therapy with anti-CTLA-4 and anti-4-1BB antibodies
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- The Availability of a Functional Tumor Targeting T-Cell Repertoire Determines the Anti-Tumor Efficiency of Combination Therapy with Anti-CTLA-4 and Anti-4-1BB Antibodies
Final published version, 2.07 MB, PDF document
It has previously been found that combination therapy with anti-CTLA-4 and anti-4-1BB antibodies may enhance tumor immunity. However, this treatment is not efficient against all tumors, and it has been suggested that variations in tumor control may reflect differences in the immunogenicity of different tumors. In the present report, we have formally tested this hypothesis. Comparing the efficiency of combination antibody therapy against two antigenically distinct variants of the B16.F10 melanoma cell line, we observed that antibody therapy delayed the growth of a variant expressing an exogenous antigen (P
Original language | English |
---|---|
Article number | e66081 |
Journal | P L o S One |
Volume | 8 |
Issue number | 6 |
Number of pages | 5 |
ISSN | 1932-6203 |
DOIs | |
Publication status | Published - 2013 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 46384334